Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
BörsenkürzelGRFS
Name des UnternehmensGrifols SA
IPO-datumMay 17, 2006
CEOAbia (Jose Ignacio)
Anzahl der mitarbeiter23833
WertpapierartDepository Receipt
GeschäftsjahresendeMay 17
AddresseParque Empresarial Can Sant Joan
StadtSANT CUGAT DEL VALLES
BörseNASDAQ OMX - NASDAQ BASIC
LandSpain
Postleitzahl08174
Telefon34935710000
Websitehttps://www.grifols.com/
BörsenkürzelGRFS
IPO-datumMay 17, 2006
CEOAbia (Jose Ignacio)